UTEP Awarded $1.2 Million by NIH to Advance Research on Diabetes-Related Cardiac Complications

November is National Diabetes Month, a time when the nation comes together to shed light on one of the leading causes of death and disability among U.S. citizens. The University of Texas at El Paso (UTEP) is joining the fight against the disease through innovative research made possible through a recent $1.2M grant by the National Institutes of Health to advance understanding of a critical diabetic heart condition.

Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.

Ultraprocessed Food: Addictive, Toxic, and Ready for Regulation

Abstract Past public health crises (e.g., tobacco, alcohol, opioids, cholera, human immunodeficiency virus (HIV), lead, pollution, venereal disease, even coronavirus (COVID-19) have been met with interventions targeted both at the individual and all of society. While the healthcare community is…

Promising New Treatment Identified for Diabetic Patients with Chronic Pain and Numbness in Their Hands and Feet

A recent study conducted by physicians across the country shows promise for a new treatment option for patients suffering chronic pain from diabetic neuropathy. The treatment entails spinal cord stimulator implantation, a technique commonly associated with chronic back and leg pain treatment.

Raising Awareness During Diabetes Awareness Month – Adult and Pediatric Diabetes Experts Available

More than 34 million people in the U.S, or 10.5% of the population, have diabetes, according to the Centers for Disease Control and Prevention. And as many as 7 million more Americans have the disease and don’t know it. Diabetes is the seventh-leading cause of death in the country..

Type 1 diabetes: Tannic acid encapsulation protects transplanted islets from rejection

Transplanting cadaver pancreatic islets is a promising therapy for Type 1 diabetes, but a reactivated autoimmunity means low graft viability after five years. Research now shows that a protective coating of two biopolymers can delay allograft and autoimmune-mediated rejection in mouse models of T1D.

University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter Member

The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance.

Mount Sinai Researchers Find That Where People Live Can Impact Their Risk for Common Chronic Conditions Including High Blood Pressure and Depression

The researchers found that a persons’ place of residence substantially influences their risk of uncontrolled chronic disease including high blood pressure and depression

15-Year Trend Persists in Disparate Insulin Pump Use in Children

Insulin pumps are widely used in the management of type 1 diabetes (T1D) and reviews have shown insulin pump therapy to be associated with improved glycemic control, fewer severe hypoglycemia events, and improved quality of life. Yet, non-Hispanic white children (NHW) are more than twice as likely as non-Hispanic Black children (NHB) to use this technology.

Genetic differences in fat shape men and women’s health risks

New findings about body fat help explain the differing health risks men and women face – and set the stage for better, more targeted treatments.

UNH Receives $1.8 Million For Biomolecular Research in Diabetes and Cancer

The University of New Hampshire will receive $1.8 million from the National Institutes of Health (NIH) that will further molecular research to better understand drug interactions at the cellular level and help lead to the development of new targeted drugs to treat wide-spread metabolic, growth, neurological and visual disorders including diabetes and cancer.

Cleveland Clinic Study Identifies Weight-Loss Threshold for Cardiovascular and Survival Benefits in Patients with Obesity and Diabetes

A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery.

Complications from diabetes linked to worse memory, IQ in children

A study led by UC Davis Health researchers uncovered that even one severe episode of diabetic ketoacidosis (DKA) in children newly diagnosed with type 1 diabetes is linked to cognitive problems; and among children with a previous diagnosis, repeated DKA exposure predicted lower cognitive performance after accounting for glycemic control.

Prevent Severe COVID Symptoms With Lifestyle Changes

Obesity is contributing to worse outcomes in people with COVID-19. Dr. Naomi Parrella, medical director of the Rush Center for Weight Loss and Bariatric Surgery, explains how managing your weight can lower your risk for severe COVID symptoms and help you prevent other chronic diseases.

Factors Inherent to Obesity Could Increase Vulnerability to COVID-19

DALLAS – Sept. 15, 2020 – Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease.

Breastfeeding’s Legacy May Protect Against Diabetes

DALLAS – Aug. 25, 2020 – Breastfeeding secures delivery of sugar and fat for milk production by changing the insulin sensitivity of organs that supply or demand these nutrients, a new study led by UT Southwestern scientists suggests. The findings, published in this month’s print issue of Diabetes, could explain how different tissues cooperate to start and maintain lactation and offer strategies to help improve breastfeeding success for mothers who have insufficient milk production.